- •There is limited available evidence on EMS providers’ exposure and infection.
- •COVID-19 is the most common infectious disease studied among EMS providers.
- •Few studies showed infection differences between age, race, gender, or work characteristics.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Infection Control
- Can methicillin-resistant Staphylococcus aureus be found in an ambulance fleet?.Prehosp Emerg Care. 2007; 11: 241-244
- Prevalence of methicillin-resistant Staphylococcus aureus in ambulances in southern Maine.Prehosp Emerg Care. 2010; 14: 176-181
- EMS provider compliance with infection control recommendations is suboptimal.Prehosp Emerg Care. 2014; 18: 290-294
- Hand hygiene in emergency medical services.Prehosp Emerg Care. 2015; 19: 313-319
- EMS disease exposure, transmission, and prevention: a review article.Curr Emerg Hosp Med Rep. 2019; 7: 135-140
Jenkins JL, Hsu EB, Russell A, Zhang A, Wilson LM, Bass EB. Infection Prevention and Control for the Emergency Medical Services and 911 Workforce. [Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 75Q80120D00003.] Rockville, MD: Agency for Healthcare Research and Quality; In Press.
- A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions.Worldviews Evid Based nurs. 2004; 1: 176-184
- Two-sided confidence intervals for the single proportion: comparison of seven methods.Stat Med. 1998; 17: 857-872
- SARS-CoV-2 seroprevalence among healthcare, first response, and public safety personnel, detroit metropolitan area, michigan, USA, May-June 2020.Emerg Infect Dis. 2020; 26: 2863-2871
- Methicillin-resistant staphylococcus aureus nasal colonization prevalence among emergency medical services personnel.Prehosp Disaster Med. 2013; 28: 348-352
- Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.Occup Environ Med. 2020; 77: 857-861
Caban-Martinez AJ, Gaglani M, Olsho LEW, et al. High burden of COVID-19 among unvaccinated law enforcement officers and firefighters. 2021. Accessed December 21, 2022. https://www.medrxiv.org/content/10.1101/2021.11.24.21266396v2
- A descriptive analysis of occupational health exposures in an urban emergency medical services system: 2007-2009.Prehosp Emerg Care. 2011; 15: 506-510
- Prevalence and characteristics of Staphylococcus aureus colonization among healthcare professionals in an urban teaching hospital.Infect Control Hosp Epidemiol. 2010; 31: 574-580
- Incidence of SARS-CoV-2 infection among health care personnel, first responders, and other essential workers during a prevaccination COVID-19 surge in Arizona.JAMA Health Forum. 2021; 2: 1-10
- Protecting the front line: a cross-sectional survey analysis of the occupational factors contributing to healthcare workers' infection and psychological distress during the COVID-19 pandemic in the USA.BMJ Open. 2020; 10e042752
- Seroprevalence of SARS-CoV-2 among firefighters/paramedics in San Francisco, CA.J Occup Environ Med. 2021; 63: e807-ee12
- Occupational exposures in emergency medical service providers and knowledge of and compliance with universal precautions.Am J Infect Control. 2010; 38: 86-94
- Prevalence of COVID-19 IgG antibodies in a cohort of municipal first responders.Prehosp Disaster Med. 2021; 36: 131-134
- Creating a safe workplace by universal testing of SARS-CoV-2 infection in asymptomatic patients and healthcare workers in the electrophysiology units: a multi-center experience.J Interv Card Electrophysiol. 2021; 62: 171-176
- Anti-SARS-CoV-2 IgA identifies asymptomatic infection in first responders.J Infect Dis. 2022; 225: 578-586
- SARS-CoV-2 seroprevalence among firefighters in Los Angeles, California.Occup Environ Med. 2022; 79: 315-318
- Occupational exposures and programmatic response to COVID-19 pandemic: an emergency medical services experience.Emerg Med J: EMJ. 2020; 37: 707-713
Newberry JA, Gautreau M, Staats K, et al. SARS-CoV-2 IgG seropositivity and acute asymptomatic infection rate among firefighter first responders in an early outbreak county in california. Prehosp Emerg Care. Published online May 6, 2021. https://doi.org/10.1080/10903127.2021.1912227.
- Methicillin-resistant Staphylococcus aureus in Ohio EMS Providers: a statewide cross-sectional study.Prehosp Emerg Care. 2016; 20: 184-190
- Medical leave associated with COVID-19 among emergency medical system responders and firefighters in New York City.JAMA Network Open. 2020; 3e2016094
- Prevalence of SARS-CoV-2 antibodies in first responders and public safety personnel, New York City, New York, USA, May-July 2020.Emerg Infect Dis. 2021; 27: 796-804
- COVID-19 exposure among first responders in Arizona.J Occup Environ Med. 2020; 62: 981-985
- Prevalence of COVID-19 amongst Arizona first responders.Biomesip. 2021; 12940 (LNCS): 371-379
- SARS-CoV-2 infection among serially tested emergency medical services workers.Prehosp Emerg Care. 2021; 25: 39-45
- SARS-CoV-2 antibody seroprevalence among firefighters in Orange County, California.Occup Environ Med. 2021; 78: 789-792
- Incidence and prevalence of antibody to hepatitis C virus in FDNY first responders before and after work at the World Trade Center disaster site.Am J Ind Med. 2018; 61: 733-740
- Pre-COVID-19 lung function and other risk factors for severe COVID-19 in first responders.ERJ Open Res. 2021; 7: 00610-02020
- 2020 National Emergency Medical Services Assessment.National Association of State EMS Officials, Falls Church, VA2020
Publication stageIn Press Journal Pre-Proof
Funding/support: This report is based on research conducted by the Johns Hopkins University Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 75Q80120D00003) with support from the National Highway Traffic Safety Administration (NHTSA). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ or NHTSA. Therefore, no statement in this report should be construed as an official position of AHRQ, the U.S. Department of Health and Human Services, NHTSA or the U.S. Department of Transportation.
Conflicts of interest: None to report.